Kura Oncology, Inc.
KURA
$9.22
-$0.52-5.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.69% | -321.50% | -36.23% | -30.07% | -15.96% |
| Total Depreciation and Amortization | 47.30% | 97.55% | -21.15% | 10.89% | 2.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.46% | 71.13% | 82.87% | -8.81% | -0.95% |
| Change in Net Operating Assets | -2.22% | -33.47% | -376.50% | 951.15% | -307.81% |
| Cash from Operations | -19.36% | -56.43% | -85.61% | 32.34% | -47.26% |
| Capital Expenditure | 56.16% | -523.92% | -- | -9,012.50% | -247.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.16% | 34.16% | 112.00% | 39.87% | -6.16% |
| Cash from Investing | 76.11% | 31.97% | 106.36% | 36.54% | -6.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.75% | 40.82% | -100.00% | -83.06% | -99.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -51.75% | 40.82% | -100.00% | -83.06% | -99.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.48% | -69.25% | 210.43% | 734.35% | -4,235.46% |